Skip to content

RadNet RDNT Additional Paid-In Capital

Additional Paid-In Capital at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$6.73B+2.1%
Danaher logo
DanaherDHR
$17.3B+2.7%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$892.95M+8.7%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$3.9B+1.2%
Tenet Healthcare logo
Tenet HealthcareTHC
$5.12B+6.2%
Teledyne Technologies logo
Teledyne TechnologiesTDY
$4.35B-0.8%

Other financials

Income statement

See full
Revenue$575.6M+22.1%
Operating income-$23.9M+0.8%
Net income-$33.5M+11.8%
EPS (diluted)-$0.43+15.7%

Balance sheet

See full
Cash & equivalents$455.3M-36.5%
Total debt$1.9B+10.8%
Total equity$1.1B+20.3%
Total assets$3.9B+16.5%

Cash flow

See full
Operating cash flow$79.0M+90.4%
CapEx$69.9M+43.2%
Free cash flow$9.0M+223%

Valuation

See full
Market cap$4.42B+17.8%

Profitability

See full
Gross margin13.4%
Operating margin2.9%-0.8pp
Net margin-0.7%-0.3pp
FCF margin5.1%+0.9pp

Returns & leverage

See full
Return on equity-1.4%-0.5pp
Debt / equity1.8×-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by RadNet in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: RadNet’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about RadNet's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RadNet's additional paid-in capital?
RadNet (RDNT) reported additional paid-in capital of $1.21B in Q1 2026.
How has RadNet's additional paid-in capital changed year-over-year?
RadNet's additional paid-in capital increased by 19.2% year-over-year, from $1.02B to $1.21B.
What is the long-term trend for RadNet's additional paid-in capital?
Over 5 years (2020 to 2025), RadNet's additional paid-in capital has grown at a 30.8% compound annual growth rate (CAGR), from $307.79M to $1.18B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.